glp-1 agonist. Classification of currently available glucagon-like peptide-1 receptor GLP-1 Agonists - FAQ —

It discusses the evidence supporting the use of glucagon-like peptide-1 receptor agonists (GLP-1RA) as potential adjunctive therapy in T1D to reduce weight and improve insulin resistance

With continued progress in our understanding of the workings and potential therapeutic advantages of GLP-1RA, these agents could radically alter the control of these conditions and improve the patients prognosis

Youve heard of the popular glucagon-like peptide-1 (GLP-1) receptor agonist drug semaglutide (Ozempic, Wegovy) and GLP-1/GIP drug tirzepatide (Mounjaro, Zepbound)

Strong results could mean another big up move in Eli Lilly's shares

The difference was driven largely by pharmacy spending